DE2512609A1 - Pharmazeutische zubereitung - Google Patents

Pharmazeutische zubereitung

Info

Publication number
DE2512609A1
DE2512609A1 DE19752512609 DE2512609A DE2512609A1 DE 2512609 A1 DE2512609 A1 DE 2512609A1 DE 19752512609 DE19752512609 DE 19752512609 DE 2512609 A DE2512609 A DE 2512609A DE 2512609 A1 DE2512609 A1 DE 2512609A1
Authority
DE
Germany
Prior art keywords
formula
hydroxy
adenine
alkyl
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752512609
Other languages
German (de)
English (en)
Inventor
Gertrude Belle Elion
George Herbert Hitchings
Paulo Manuel Slvador D Miranda
Howard John Schaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2512609A1 publication Critical patent/DE2512609A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752512609 1975-02-13 1975-03-21 Pharmazeutische zubereitung Ceased DE2512609A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6173/75A GB1530912A (en) 1975-02-13 1975-02-13 Compositions containing 9-(2-hydroxy-3-alkyl)-adenines

Publications (1)

Publication Number Publication Date
DE2512609A1 true DE2512609A1 (de) 1976-08-26

Family

ID=9809759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752512609 Ceased DE2512609A1 (de) 1975-02-13 1975-03-21 Pharmazeutische zubereitung

Country Status (10)

Country Link
US (1) US4315920A (enExample)
AT (1) AT343276B (enExample)
BE (1) BE826935A (enExample)
CA (1) CA1054521A (enExample)
DE (1) DE2512609A1 (enExample)
GB (1) GB1530912A (enExample)
IN (1) IN141900B (enExample)
NZ (1) NZ176971A (enExample)
ZA (1) ZA751650B (enExample)
ZM (1) ZM5975A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530142A1 (fr) * 1982-07-08 1984-01-20 Yamasa Shoyu Kk Composition contenant un agent renforcant les effets antitumoraux, et medicament comprenant une substance antitumorale et un tel agent

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
WO1997028803A1 (en) * 1996-02-12 1997-08-14 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DK1790344T3 (da) 2000-07-07 2011-05-02 Spectrum Pharmaceuticals Inc Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal Medical Chemistry, 17, 1, 1974, S. 6-8 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530142A1 (fr) * 1982-07-08 1984-01-20 Yamasa Shoyu Kk Composition contenant un agent renforcant les effets antitumoraux, et medicament comprenant une substance antitumorale et un tel agent

Also Published As

Publication number Publication date
CA1054521A (en) 1979-05-15
IN141900B (enExample) 1977-04-30
US4315920A (en) 1982-02-16
AU7934275A (en) 1976-09-23
GB1530912A (en) 1978-11-01
ZA751650B (en) 1976-10-27
ATA207275A (de) 1977-09-15
BE826935A (fr) 1975-09-22
AT343276B (de) 1978-05-26
ZM5975A1 (en) 1977-01-21
NZ176971A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
DE69132389T2 (de) 2-aralkoxy und 2-alkoxy-adenosinderivate als koronarvasodilatoren und antihypertensive stoffe
DE69733353T2 (de) Immunsuppressive wirkstoffe und verfahren
DE2065635C3 (de) 10-Dioxo-11 -methyldibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
CH623587A5 (enExample)
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE2718669C2 (enExample)
DE2141634C3 (de) Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten
DE2512609A1 (de) Pharmazeutische zubereitung
EP0192056B1 (de) Verfahren zur Herstellung von Labdan-Derivaten und ihre Verwendung als Arzneimittel
DE2124640C2 (de) 1-Methyl-9,10-dihydrolysergyl-omega-nitro-L-argininol sowie seine Salze und diese Verbindungen enthaltende Arzneimittel
DE3009071A1 (de) 2-isopropylaminopyrimidinhydroxyderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2858078C2 (de) 2-Chlorethylnitrosoharnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE3789290T2 (de) Theophyllinmethyldithiolan und Theophyllinmethyldithianylderivate, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE2708826A1 (de) Substituierte 8-azapurine und verfahren zu ihrer herstellung
DE2709497A1 (de) Nitroso-harnstoff-verbindungen, verfahren zur herstellung und daraus hergestellte arzneimittel
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE3021169A1 (de) Pivaloyloxymethyl-2-propylpentanoat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE2410201C3 (de) 6-Substituierte 3-Carbäthoxyhydrazinopyridazine beziehungsweise ihre Salze sowie solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE2921844C2 (de) 1-(2-Chlorethyl)-1-nitroso-3-substituierte-3-glycosylharnstoffe, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
CH643862A5 (de) Bis(4-demethoxydaunorubicin)dihydrazon-derivate und sie enthaltende pharmazeutische zubereitungen.
DE2917890C2 (enExample)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection